Cell and gene therapies - life saving opportunity for many patients
Read moreThis resolution includes proposed reforms to the market access (including pricing) landscape designe...
Read moreThis study investigates costs of gene/acute therapies versus chronic treatments for rare diseases, o...
Read moreFollowing a series of FOI requests to CCGs, MTG said a number of CCGs are currently restricting acce...
Read moreNHS England’s cost-effectiveness watchdog, (NICE), issued a first draft document saying that it di...
Read moreFaster access to new treatments for very rare conditions announced following a revised decision maki...
Read moreThe development of gene therapies represents a new frontier of science, with the potential to help p...
Read moreThis study investigates the efficiency of the new CDF appraisal process for indications without prio...
Read moreThis study investigates NICE's evaluation of existing CDF treatments and its potential impact on fun...
Read more